Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.796
+0.001 (0.16%)
Nov 21, 2024, 4:00 PM EST - Market closed
Vor Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 52.8 | 31.36 | 57.71 | 119.8 | 48.54 | 6.47 | Upgrade
|
Short-Term Investments | 10.01 | 105.82 | 172.54 | 87.67 | - | - | Upgrade
|
Cash & Short-Term Investments | 62.81 | 137.18 | 230.25 | 207.47 | 48.54 | 6.47 | Upgrade
|
Cash Growth | -60.77% | -40.42% | 10.98% | 327.43% | 650.68% | 596.02% | Upgrade
|
Prepaid Expenses | 4.2 | 3.15 | 4.37 | 4.84 | 0.47 | 0.87 | Upgrade
|
Other Current Assets | 0.29 | 0.48 | 2.34 | 2.09 | 0.1 | 0.21 | Upgrade
|
Total Current Assets | 67.3 | 140.8 | 236.95 | 214.4 | 49.11 | 7.54 | Upgrade
|
Property, Plant & Equipment | 43.77 | 50.1 | 57.08 | 22.52 | 21.85 | 0.73 | Upgrade
|
Other Long-Term Assets | 4.93 | 7.23 | 5.34 | 5.67 | 4.96 | 1.56 | Upgrade
|
Total Assets | 115.99 | 198.13 | 299.37 | 242.59 | 75.91 | 9.83 | Upgrade
|
Accounts Payable | 1.32 | 0.82 | 1.77 | 1.55 | 2.36 | 0.69 | Upgrade
|
Accrued Expenses | 8.87 | 10.93 | 8.08 | 6.34 | 6.26 | 0.94 | Upgrade
|
Current Portion of Leases | 4.16 | 3.83 | 3.27 | 1.84 | 0.86 | - | Upgrade
|
Other Current Liabilities | - | - | - | 0.43 | 0.72 | 0.56 | Upgrade
|
Total Current Liabilities | 14.35 | 15.57 | 13.12 | 10.15 | 10.21 | 2.19 | Upgrade
|
Long-Term Leases | 28.69 | 31.83 | 35.64 | 16.17 | 17.43 | - | Upgrade
|
Total Liabilities | 43.04 | 47.4 | 48.76 | 26.33 | 27.64 | 2.19 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | - | Upgrade
|
Additional Paid-In Capital | 499.16 | 490.87 | 473.59 | 346.38 | 2.16 | 0.46 | Upgrade
|
Retained Earnings | -426.28 | -340.08 | -222.22 | -130.12 | -61.22 | -17.89 | Upgrade
|
Comprehensive Income & Other | 0.07 | -0.08 | -0.77 | - | - | - | Upgrade
|
Total Common Equity | 72.96 | 150.72 | 250.61 | 216.26 | -59.07 | -17.43 | Upgrade
|
Shareholders' Equity | 72.96 | 150.72 | 250.61 | 216.26 | 48.27 | 7.64 | Upgrade
|
Total Liabilities & Equity | 115.99 | 198.13 | 299.37 | 242.59 | 75.91 | 9.83 | Upgrade
|
Total Debt | 32.85 | 35.66 | 38.91 | 18.01 | 18.29 | - | Upgrade
|
Net Cash (Debt) | 29.96 | 101.52 | 191.33 | 189.46 | 30.25 | 6.47 | Upgrade
|
Net Cash Growth | -75.75% | -46.94% | 0.99% | 526.38% | 367.77% | - | Upgrade
|
Net Cash Per Share | 0.44 | 1.51 | 4.84 | 5.67 | 141.56 | 56.25 | Upgrade
|
Filing Date Shares Outstanding | 68.67 | 68.17 | 66.37 | 37.49 | 37.13 | 0.12 | Upgrade
|
Total Common Shares Outstanding | 68.66 | 67.89 | 66 | 37.17 | 0.51 | 0.12 | Upgrade
|
Working Capital | 52.95 | 125.23 | 223.83 | 204.25 | 38.9 | 5.35 | Upgrade
|
Book Value Per Share | 1.06 | 2.22 | 3.80 | 5.82 | -116.94 | -145.30 | Upgrade
|
Tangible Book Value | 72.96 | 150.72 | 250.61 | 216.26 | -59.07 | -17.43 | Upgrade
|
Tangible Book Value Per Share | 1.06 | 2.22 | 3.80 | 5.82 | -116.94 | -145.30 | Upgrade
|
Machinery | 17.59 | 17.4 | 15.64 | 8.77 | 5.45 | 0.85 | Upgrade
|
Construction In Progress | 0.04 | 0.15 | 1.04 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.